Oxybutynine Teva (Oxybutynin Hydrochloride)

Oxybutynin hydrochloride, the active ingredient in Oxybutynine Teva, is an antispasmodic anticholinergic presented as a tablet for oral use. It treats overactive bladder symptoms such as urgency, frequency, and urge incontinence in adults. GNH USA supplies Oxybutynine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxybutynine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxybutynine Teva is an anticholinergic medication that acts on the urinary bladder smooth muscle to reduce involuntary contractions.

- Overactive bladder: Improves bladder capacity and reduces urgency episodes. - Urge urinary incontinence: Decreases the frequency of leakage episodes. - Detrusor overactivity associated with neurological conditions: Helps control involuntary bladder contractions.

Oxybutynine Teva may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects: - Dry dry   -    a   -    -  t  -  -  - 

Serious or Rare Side Effects: -  t  t -   t -  t -  t -  t

Oxybutin   a  t  ewline    ewline   ewline  ewline  ewline \n t   ewline \\